The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Medical - Pharmaceuticals industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
20 of 153
P/E 32.8 vs period average 7.3 Richer than its history
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/3 |  | $330.46 | 931.0 | 9 | 96 | 96 | 100 |
| 2/3 |  | $17.47 | — | 43 | 61 | 30 | 31 |
| 3/3 |  | $7.18 | — | 17 | 30 | 35 | 17 |
| — |  | $27.79 | — | — | — | — | — |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Upgrades and downgrades on the sector's stocks
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $9B | 0.44% |
| XLVState Street Health Care Select Sector SPDR ETF | 100.0% | $43B | 0.08% |
| VHTVanguard Health Care ETF | 100.0% |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
| $20B |
| 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.38% |
The percentage is the sector's share of the fund's assets, per the latest available data.